Results 151 to 160 of about 102,281 (237)

Precision medicine for Defence? [PDF]

BMJ Mil Health
Armstrong SJ, King K, Steventon G.
europepmc   +1 more source

Structural Impact of 4-Hydroxynonenal Modification on Human Cytochrome CYP4F11. [PDF]

ChemMedChem
Gnatyuk O, Skorokhod O, Damin A, Chaika M, Naeimaeirouhani F, Pica L, Tomatis A, Smorygo A, Voitsitskyi T, Catucci G, Dovbeshko G, Gilardi G.   +11 more
europepmc   +1 more source

A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile.

J Clin Endocrinol Metab
Rojas Velazquez MN, Lopez Dacal J, Jørgensen FS, Sanguineti N, Sharma K, Marino R, Pérez Garrido N, Vaiani E, Ramírez P, Scaglia P, Izquierdo A, Sansó G, Ropelato MG, Bergadá I, Rey RA, Grinspon RP, Pandey AV.   +16 more
europepmc   +1 more source

Functional Characterization of <i>Eccyp307a1</i> in Early Ovary Development of <i>Exopalaemon carinicauda</i>. [PDF]

Int J Mol Sci
Jia S, Pan X, Hou Y, Gong K, Su Y, Lv J, Li J.   +6 more
europepmc   +1 more source

Nephrotoxicity of halogenated inhalational anaesthetics: Fictions and facts [PDF]

, 2002
Conzen, Peter F., Peter, Klaus, Reichle, Florian M.   +2 more
core   +1 more source

Cytochrome P450 enzymes as modulators of oncogenic signaling via the Wnt/β-catenin signaling pathway. [PDF]

Arch Toxicol
Braeuning A.
europepmc   +1 more source

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice. [PDF]

Clin Pharmacol Drug Dev
Alabi A, Kerr JS, Shah M, Khan A, Ma JD, Suhandynata RT, Momper JD, Tsunoda SM.   +7 more
europepmc   +1 more source

Biogenesis of Organelles and Membrane Proteins. [PDF]

, 1988
Harmey, Matthew A., Neupert, Walter, Nicholson, Donald W., Stuart, Rosemary A.   +3 more
core   +1 more source

Effects of Botrychium ternatum (Thunb) Sw. On Cytochrome P450 Activities in Rats. [PDF]

Pharmacol Res Perspect
Yao J, Hu L, Zhou Q, Al Mamun A, Wang S, Han A.   +5 more
europepmc   +1 more source

Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Jaiswal S, Patel NK, Jones HM, McFeely S, Faison SL, Tippin T, Naderer O.   +6 more
europepmc   +1 more source